Guardant Health (GH) Operating Expenses (2017 - 2026)

Guardant Health has reported Operating Expenses for 10 years, with the latest figure at $464.1 million in Q2 2026.

• Quarterly Operating Expenses rose 37.1% year-over-year to $464.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.7 billion (up 28.21% YoY) and the FY2025 annual result came in at $1.4 billion, up 20.01% from the prior year.
• Operating Expenses climbed to $464.1 million in Q2 2026 per GH's latest filing, from $423.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $464.1 million in Q2 2026 and troughed at $219.4 million in Q1 2022.
• A 5-year average of $311.8 million and a median of $293.3 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2024 and 2026: Operating Expenses retreated 7.03% in 2024, then soared 37.1% in 2026.
• Over 5 years, Operating Expenses stood at $273.0 million in 2022, then increased by 29.14% to $352.6 million in 2023, then retreated by 7.03% to $327.8 million in 2024, then grew by 22.67% to $402.1 million in 2025, then gained by 15.43% to $464.1 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $464.1 million, $423.0 million, and $402.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.